SIAH-1 interacts with the Kaposi's sarcoma-associated herpesvirus-encoded ORF45 protein and promotes its ubiquitylation and proteasomal degradation

被引:21
作者
Abada, Rinat [1 ]
Dreyfuss-Grossman, Tsofia [1 ]
Herman-Bachinsky, Yifat [1 ]
Geva, Haim [1 ]
Masa, Shiri-Rivka [1 ]
Sarid, Ronit [1 ]
机构
[1] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel
关键词
D O I
10.1128/JVI.02285-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Kaposi's sarcoma-associated herpesvirus (KSHV), also referred to as human herpesvirus 8, is a potentially tumorigenic virus implicated in the etiology of Kaposi's sarcoma, primary effusion lymphoma, and some forms of multicentric Castleman's disease. The open reading frame 45 (ORF45) protein, encoded by the KSHV genome, is capable of inhibiting virus-dependent interferon induction and appears to be essential for both early and late stages of infection. In the present study, we show, both in yeast two-hybrid assays and in mammalian cells, that the ORF45 protein interacts with the cellular ubiquitin E3 ligase family designated seven in absentia homologue (SIAH). We provide evidence that SIAH-1 promotes the degradation of KSHV ORF45 through a RING domain-dependent mechanism and via the ubiquitin-proteasome system. Furthermore, our data indicate the involvement of SIAH-1 in the regulation of the expression of ORF45 in KSHV-infected cells. Since the availability of KSHV ORF45 is expected to influence the course of KSHV infection, our findings identify a novel biological role for SIAH proteins as modulators of virus infection.
引用
收藏
页码:2230 / 2240
页数:11
相关论文
共 48 条
[1]   The tumor suppressor protein p16INK4a and the human papillomavirus oncoprotein-58 E7 are naturally occurring lysine-less proteins that are degraded by the ubiquitin system -: Direct evidence for ubiquitination at the N-terminal residue [J].
Ben-Saadon, R ;
Fajerman, I ;
Ziv, T ;
Hellman, U ;
Schwartz, AL ;
Ciechanover, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (40) :41414-41421
[2]   The polycomb protein Ring1B generates self atypical mixed ubiquitin chains required for its in vitro histone H2A ligase activity [J].
Ben-Saadon, Ronen ;
Zaaroor, Daphna ;
Ziv, Tamar ;
Ciechanover, Aaron .
MOLECULAR CELL, 2006, 24 (05) :701-711
[3]   Regulation of BOB.1/OBF.1 stability by SIAH [J].
Boehm, J ;
He, YS ;
Greiner, A ;
Staudt, L ;
Wirth, T .
EMBO JOURNAL, 2001, 20 (15) :4153-4162
[4]   IDENTIFICATION OF HERPESVIRUS-LIKE DNA-SEQUENCES IN AIDS-ASSOCIATED KAPOSIS-SARCOMA [J].
CHANG, Y ;
CESARMAN, E ;
PESSIN, MS ;
LEE, F ;
CULPEPPER, J ;
KNOWLES, DM ;
MOORE, PS .
SCIENCE, 1994, 266 (5192) :1865-1869
[5]   Kaposi's sarcoma-associated herpesvirus: Clinical, diagnostic, and epidemiological aspects [J].
Cohen, A ;
Wolf, DG ;
Guttman-Yassky, E ;
Sarid, R .
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2005, 42 (02) :101-153
[6]   A crosstalk between hSiah2 and Pias E3-ligases modulates Pias-dependent activation [J].
Depaux, A. ;
Regnier-Ricard, F. ;
Germani, A. ;
Varin-Blank, N. .
ONCOGENE, 2007, 26 (46) :6665-6676
[7]   Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) epidemiology and pathogenesis [J].
Dourmishev, LA ;
Dourmishev, AL ;
Palmeri, D ;
Schwartz, RA ;
Lukac, DM .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2003, 67 (02) :175-+
[8]   Human herpesvirus 8-A novel human pathogen [J].
Edelman, Daniel C. .
VIROLOGY JOURNAL, 2005, 2 (1)
[9]   Siah-1b is a direct transcriptional target of p53:: Identification of the functional p53 responsive element in the siah-1b promoter [J].
Fiucci, G ;
Beaucourt, S ;
Duflaut, D ;
Lespagnol, A ;
Stumptner-Cuvelette, P ;
Géant, A ;
Buchwalter, G ;
Tuynder, M ;
Susini, L ;
Lassalle, JM ;
Wasylyk, C ;
Wasylyk, B ;
Oren, M ;
Amson, R ;
Telerman, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (10) :3510-3515
[10]   SIAH-1 interacts with α-tubulin and degrades the kinesin Kid by the proteasome pathway during mitosis [J].
Germani, A ;
Bruzzoni-Giovanelli, H ;
Fellous, A ;
Gisselbrecht, S ;
Varin-Blank, N ;
Calvo, F .
ONCOGENE, 2000, 19 (52) :5997-6006